[{"Assets_0_Q2_USD":21759000000.0,"EarningsPerShareBasic_1_Q2_USD":4.07,"EarningsPerShareBasic_2_Q2_USD":7.53,"EarningsPerShareDiluted_1_Q2_USD":4.07,"EarningsPerShareDiluted_2_Q2_USD":7.52,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1404400000.0,"NetIncomeLoss_1_Q2_USD":862800000.0,"NetIncomeLoss_2_Q2_USD":1610400000.0,"StockholdersEquity_0_Q2_USD":11585200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":212200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":214000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":211900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":213700000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170725"}]